These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21426047)

  • 1. Inosine monophosphate dehydrogenase as a target for antiviral, anticancer, antimicrobial and immunosuppressive therapeutics.
    Braun-Sand SB; Peetz M
    Future Med Chem; 2010 Jan; 2(1):81-92. PubMed ID: 21426047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of curcumin on IMP dehydrogenase, the target for anticancer and antiviral chemotherapy agents.
    Dairaku I; Han Y; Yanaka N; Kato N
    Biosci Biotechnol Biochem; 2010; 74(1):185-7. PubMed ID: 20057137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery.
    Shu Q; Nair V
    Med Res Rev; 2008 Mar; 28(2):219-32. PubMed ID: 17480004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
    Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
    Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel inhibitors of inosine monophosphate dehydrogenase in patent literature of the last decade.
    Petrelli R; Vita P; Torquati I; Felczak K; Wilson DJ; Franchetti P; Cappellacci L
    Recent Pat Anticancer Drug Discov; 2013 May; 8(2):103-25. PubMed ID: 23016672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor.
    Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The determination and clinical application of inosine 5’-monophosphate dehydrogenase activity].
    Liu FY; Qiu XY; Jiao Z
    Yao Xue Xue Bao; 2016 Nov; 51(11):1666-73. PubMed ID: 29908108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
    Nair V; Shu Q
    Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
    Vethe NT; Bergan S
    Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
    Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
    Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inosine 5'-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases.
    Ratcliffe AJ
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):595-605. PubMed ID: 17002220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent development of IMP dehydrogenase inhibitors for the treatment of cancer.
    Chen L; Pankiewicz KW
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):403-12. PubMed ID: 17659481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones.
    Barnes BJ; Eakin AE; Izydore RA; Hall IH
    Biochemistry; 2000 Nov; 39(45):13641-50. PubMed ID: 11076502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
    Shah CP; Kharkar PS
    Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent "fat base" nucleotide inhibitor of IMP dehydrogenase.
    Wang W; Hedstrom L
    Biochemistry; 1998 Aug; 37(34):11949-52. PubMed ID: 9718319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inosine 5'-monophosphate dehydrogenase inhibitors as antimicrobial agents: recent progress and future perspectives.
    Shah CP; Kharkar PS
    Future Med Chem; 2015; 7(11):1415-29. PubMed ID: 26230881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells.
    Khan M; Dhanwani R; Patro IK; Rao PV; Parida MM
    Antiviral Res; 2011 Jan; 89(1):1-8. PubMed ID: 21070810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic mechanism of human inosine 5'-monophosphate dehydrogenase type II: random addition of substrates and ordered release of products.
    Wang W; Hedstrom L
    Biochemistry; 1997 Jul; 36(28):8479-83. PubMed ID: 9214292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The basic functions of inosine 5'-monophosphate dehydrogenase and its application in drug discovery].
    Zhang YW; Zhang D; Sun H
    Yao Xue Xue Bao; 2014 Mar; 49(3):285-92. PubMed ID: 24961097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-dimensional pharmacophore model for IMPDH inhibitors.
    Yang N; Wang J; Li J; Wang QH; Wang Y; Cheng MS
    Chem Biol Drug Des; 2011 Jul; 78(1):175-82. PubMed ID: 21507206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.